Intrexon Corporation, a next generation synthetic biology company, today
announced the appointment of Cary P. Moxham, Ph.D., as VP of Alliance
Management for its Human Therapeutics alliances. Dr. Moxham’s leadership
activities will be focused, first and foremost, on Intrexon’s exclusive
channel partnership with ZIOPHARM Oncology, Inc., ...
read more